CNBC's Meg Tirrell, and Michael Pellini, Foundation Medicine president & CEO, discuss the benefits of Roche's majority stake in Foundation Medicine.
In the first post-Steve Ballmer sale of an NBA team, many wonder who will buy the Atlanta Hawks——and for how much.
Matt Murray, The Wall Street Journal, and Alan Murray, Fortune editor, discuss word Yahoo is looking to acquire a cable asset.
Campbell Soup Company CEO Denise Morrison, shares her consumer forecast, and discusses how her company is making products more available to consumers.
CNBC's David Faber reports Canada's Talisman Energy has agreed to be acquired by Spain's Repsol for $3.8 billion. Jim Cramer provides insight on the deal.
PetSmart has agreed to be acquired by a consortium controlled by BC partners for $8.2 billion. CNBC's Jim Cramer and David Faber break down the deal.
PetSmart agreed to sell itself to a private equity consortium for $8.7 billion, in the largest leveraged buyout of the year.
Following Merck's acquisition of Cubist, chairman and CEO Kenneth Frazier discusses innovation possibilities the deal presents for public health, with CNBC's Meg Tirrell.
Michael Lynch, Autonomy founder, discusses "accounting misrepresentations" involving Autonomy after it was sold to Hewlett-Packard back in 20111 for $11 billion.
CNBC's David Faber discusses the future of Vodafone after reports of a potential acquisition of Liberty Global surfaced in a story by Bloomberg.
The Fast Money traders discuss Twitter's potential acquisition of "Shots," the Justin Bieber backed selfie app run by John Shahidi.
Brian Whiteman, GrooveBook founder; discusses how he got the idea to start his photobook company. And Jeffrey Housenbold, Shutterfly president & CEO, shares his outlook for GrooveBook.
Discussing Shutterfly's $14.5 million acquisition of "Shark Tank" backed GrooveBook, with Brian Whiteman, GrooveBook founder; Jeffrey Housenbold, Shutterfly president & CEO, and Kevin O'Leary, "Shark Tank" investor.
AstraZeneca said it had made good progress in developing a pipeline of new drugs.
Actavis is nearing a deal to acquire Allergan in a cash and stock deal worth more than $210 per Allergan share, sources tell CNBC.
Discussing the price of Warren Buffett's acquisition of Duracell from Procter & Gamble, Nik Modi, RBC Capital Markets, explains why it seem like the perfect fit for the way Berkshire philosophically thinks about assets.
Warren Buffett is buying Duracell from Procter & Gamble. CNBC's Jim Cramer breaks down the deal.
The "Squawk Box" news team discusses Berkshire's acquisition of Duracell from Procter & Gamble.
Yahoo will acquire video advertising network Brightroll in an all-cash deal valued at $640 million.
Elliott Management sent a letter to Family Dollar's board, nominating seven new directors on Friday.